• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Tris Pharma® Acquires Park Therapeutics americanpharmaceuticalreview
    April 30, 2021
    Tris Pharma, Inc., a specialty pharmaceutical company with a portfolio of approved products and a late-stage pipeline of product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related conditions, has acquired Park ...
  • HCmed joins Wuxi life science innovation park biospectrumasia
    September 08, 2019
    HCmed specializes on the development of handheld devices for inhaled drug delivery therapy.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service